Despite recent advances in the field of allogeneic hematopoietic stem cell transplantation
(HSCT), viral infections are still a major complication during the period of immune …

Background Allogeneic hematopoietic stem cell transplantation (HSCT) can expose patients
to a transient but marked immunosuppression, during which viral infections are an important …

Viral infections remain a major risk in immunocompromised pediatric patients, and virus-
specific T cell (VST) therapy has been successful for treatment of refractory viral infections in …

Purpose Reactivation of Epstein-Barr virus (EBV) after allogeneic stem-cell transplantation
(SCT) can lead to severe life-threatening infections and trigger post-transplantation …

Post-transplant lymphoproliferative diseases (PTLD) associated with Epstein-Barr virus
(EBV) infection often develop after organ and haematopoietic stem-cell transplantation …

Post-transplant lymphoproliferative disorders (PTLDs) are a group of conditions that involve
uncontrolled proliferation of lymphoid cells as a consequence of extrinsic …

Allogeneic hematopoietic stem cell transplantation is a successful treatment for hematologic
malignancies and a variety of genetic and metabolic disorders. In the period following stem …

Approximately 12% of all cancers worldwide are associated with viral infections. To date,
eight viruses have been shown to contribute to the development of human cancers …

EBV-induced post transplantation lymphoproliferative disorder (EBV-PTLD) is a life-
threatening complication after allogeneic hematopoietic cell transplantation. Profound T-cell …

We analyzed the outcome of allogeneic hematopoietic stem cell transplantation (HSCT) over
the past 2 decades. Between 1992 and 2009, 953 patients were treated with HSCT, mainly …